Read more about these guidelines here

Goodman and colleagues stress that the ACR–AAHKS guidelines “are not treatment mandates,” but rather “provide the backbone for a shared decision-making process between patient and physician regarding perioperative medication management.”

They note, however, that the guidelines “are relevant to physicians treating KD regardless of their area of expertise.”

Conversely, the current recommendations “stress the early use of conventional synthetic and biologic DMARDs and the avoidance of glucocorticoids and NSAIDs,” she added, noting that “for systemic JIA the guidelines suggest using biologic DMARDs as a first line.”

Clinical practice guidelines have been developed to advise on the role of plasma exchange and the optimal dose of glucocorticoids in people with antineutrophil cytoplasmic antibody-associated vasculitis.

The American College of Rheumatology and the Vasculitis Foundation have issued joint guidelines for the management of various types of vasculitis.

The guidelines – published simultaneously in Arthritis & Rheumatology and Arthritis Care & Research – form an update to the 2015 guidelines and comprise 44 recommendations (seven strong and 37 conditional) related to the initiation and adjustment of DMARD therapy.

The American College of Rheumatology has issued updated guidelines for the management of gout.

Boumpas and team note that the previous iteration of the LN guidelines was published in 2012, and “[s]ince then, new evidence has emerged, which includes the use of calcineurin inhibitors (CNIs) and ‘multitarget’ therapy, disease monitoring and treatment targets.”

The British Society for Rheumatology has issued updated guidelines for the diagnosis and treatment of giant cell arteritis.

Updated evidence-based guidelines for the management of hand, hip, and knee osteoarthritis in the USA have been issued by the ACR and the Arthritis Foundation.

Updated evidence-based guidelines for the management of hand, hip, and knee osteoarthritis in the USA have been issued by the ACR and the Arthritis Foundation.

The ACR has released guidelines for reproductive healthcare among people with rheumatic and musculoskeletal diseases.

Exercise is key A particular focus of the latest guidelines is exercise, with strong recommendations for exercise given for all types of OA covered by the guidelines “We need to stress that [exercise] really is the cornerstone of management for osteoarthritis overall,” says Kolasinski.

Sharon Kolasinski talks about what’s new in the latest ACR–Arthritis Foundation recommendations for the management of osteoarthritis, and highlights the key take-home messages for healthcare providers.

In the second of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the implications and limitations of the recent ACR–NPF guidelines for the management of psoriatic arthritis, together with key clinical trials that have been published since the guidelines were released.

In the first of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the development of the recent ACR–NPF guidelines for the management of psoriatic arthritis, and the key differences between these and the EULAR and GRAPPA guidelines.

In the first of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the development of the recent ACR–NPF guidelines for the management of psoriatic arthritis, and the key differences between these and the EULAR and GRAPPA guidelines.

The guidelines are published simultaneously in Arthritis Care & Research and Arthritis & Rheumatology .

These guidelines, developed through a systematic review and expert consensus process, “have taken a more patient-centered approach than earlier versions by allowing recommendations to be predicated on the distribution of osteoarthritis and various comorbidity profiles,” Raveendhara Bannuru (Tufts Medical Center, Boston, Massachusetts, USA) and co-authors write in Osteoarthritis & Cartilage .